Bivalirudin 1-11 Fragment Trifluoroacetic Acid Salt

IMPURITIES

Product Details

CAT No.# CS-O-14543
Category Impurities
CAS NA
Molecular Weight 1143.9
Molecular Formula C45H65F3N16O16
Purity: >98%
Synonyms: 1-11 Bivalirudin Fragment Trifluoroacetic Acid Salt ; trifluoroacetic acid; α-aspartylglycylasparagylglycylglycylglycylglycylprolylarginylprolyl(D)phenylalanyl
Application Notes: Impurity in commercial preparation of Bivalirudin ,Bivalirudin 1-11 Fragment is an impurity of Bivalirudin, a direct thrombin inhibitor acting as an anticoagulant through inhibition of the enzyme thrombin.
References: Bertrand, O. et al.: Am. J. Cardio., 110, 599 (2012); Patti, G. et al.: Am. J. Cardio., 110, 478 (2012)
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


SMILES:
NC([C@@H](NC(CNC([C@@H](NC(CNC(CNC(CNC(CNC([C@@H]1CCCN1C([C@@H](NC([C@@H]2CCCN2C([C@@H](CC3=CC=CC=C3)N)=O)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)CC(N)=O)=O)=O)CC(O)=O)=O.FC(C(O)=O)(F)F



This page contains information about Bivalirudin 1-11 Fragment Trifluoroacetic Acid Salt Cas NA and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."